Biotex, a biotechnology company, is facing a lawsuit from a scientist who claims to have patented a protein that cures cancer. Biotex wants to avoid paying the $20 million in royalties demanded by the scientist. The document discusses analyzing the type of patent the scientist filed to determine if Biotex is obligated to pay, as well as options like challenging the patent or developing an alternative to the protein.